Fawzy; Nagy E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fawzy; Nagy E..The latest application filed is for "salt forms of 4-cyano-n-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahyd- ro-2h-pyran-4-yl)pyridin-3-yl)-1h-imidazole-2-carboximide".

Company Profile

7.5.8

Fawzy; Nagy E. - Piscataway NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Salt Forms Of 4-Cyano-N-(4,4-Dimethylcyclohex-1-EN-1-YL)-6-(2,2,6,6-Tetramethyltetrahyd- ro-2H-Pyran-4-YL)Pyridin-3-YL)-1H-Imidazole-2-Carboximide App 20210053951 - Fawzy; Nagy E. ; et al.	2021-02-25
Salt forms of 4-cyano-N-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-Tetr amethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboximide Grant 10,858,348 - Fawzy , et al. December 8, 2	2020-12-08
Salt Forms Of 4-Cyano-N-(4,4-Dimethylcyclohex-1-EN-1-YL)-6-(2,2,6,6-Tetramethyltetrahyd- ro-2H-Pyran-4-YL)Pyridin-3-YL)-1H-Imida App 20200140421 - Fawzy; Nagy E. ; et al.	2020-05-07
Salt forms of 4-cyano-n-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahyd- ro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide Grant 10,562,892 - Fawzy , et al. Feb	2020-02-18
Salt Forms Of 4-cyano-n-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahyd- Ro-2h-pyran-4-yl)pyridin-3-yl)-1h-imida App 20190194175 - Fawzy; Nagy E. ; et al.	2019-06-27
Crystalline forms of 4-cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetra- hydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide Grant 10,314,821 - Fawzy , et al.	2019-06-11
Salt forms of 4-cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetra- hydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide Grant 10,266,522 - Fawzy , et al.	2019-04-23
Anhydrous Crystalline Form Of (1s)-1,5-anhydro-1-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphen- Yl]-d-glucitol App 20180155329 - Breslin; David T. ; et al.	2018-06-07
Crystalline Forms Of 4-cyano-n-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetra- Hydro-2h-pyran-4-yl)pyridin-3-yl)-1h-imidazole-2-carboxamide App 20180133197 - FAWZY; Nagy E. ; et al.	2018-05-17
Salt Forms Of 4-cyano-n-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetra- Hydro-2h-pyran-4-yl)pyridin-3-yl)-1h-imidazole-2-carboxamide App 20180016264 - FAWZY; Nagy E. ; et al.	2018-01-18
Fused cyclopentyl antagonists of CCR2 Grant 8,822,460 - Winters , et al. September 2, 2	2014-09-02
Fused Cyclopentyl Antagonists Of Ccr2 App 20140018356 - Winters; Michael P. ; et al.	2014-01-16
Crystalline Forms Of 4-[6-(6-methanesulfonyl-2-methyl-pyridin-3-ylamino)-5-methoxy-pyrimidin-4- -yloxy]-piperidine-1-carboxylic Acid Isopropyl Ester App 20110015215 - Deghetto; Paul ; et al.	2011-01-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.